© 2010 Canadian Medical Association or its licensors

Self-monitoring of blood glucose in patients with dia-betes who use insulin may contribute to improvedglycemic control and reduced hypoglycemia by allowing for self-adjustments in insulin dose to be made based on meter readings.1 Self-monitoring may also allow for appropriate changes in diet and physical activity to be made. However, the benefits of self-monitoring of blood glucose for patients not using insulin are less clear. Hypo-glycemia is less frequent in this population2 and is confined mainly to those taking secretagogues. The degree to which patients can adjust the dose of oral antidiabetes drugs in response to readings is limited. Nevertheless, self-monitoring of blood glucose is routinely recommended for patients who are not using insulin.1 This results in major investments in this technology by patients and payers.3 In 2006, $250 million was spent on blood glu-cose test strips in 8 publicly funded drugs plans in Newfound